Designed exclusively for in vitro diagnostic use, the Atellica™ CH Complement C4 (C4) assay enables precise quantitative determination of complement C4 levels in human serum, utilizing the advanced Atellica™ CH Analyzer.
Essential for accurately diagnosing inherited or acquired deficiencies, the assay plays a critical role in the evaluation of inflammatory and necrotic disorders by measuring complement C4 levels.
Complies with safety standards, carrying a warning for potential cancer and reproductive harm as per www.P65Warnings.ca.gov for informed use.